REAL WORLD PERSISTENCE AND ADHERENCE WITH ORAL BISPHOSPHONATES FOR OSTEOPOROSIS - A SYSTEMATIC REVIEW

被引:1
|
作者
Fatoye, F. [1 ]
Smith, P. [1 ]
Gebrye, T. [1 ]
Yeowell, G. [1 ]
机构
[1] Manchester Metropolitan Univ, Manchester, Lancs, England
关键词
D O I
10.1016/j.jval.2018.09.1802
中图分类号
F [经济];
学科分类号
02 ;
摘要
PMS88
引用
收藏
页码:S302 / S303
页数:3
相关论文
共 50 条
  • [41] Real-World Adherence and Persistence with Direct Oral Anticoagulants in Adults with Atrial Fibrillation
    Manzoor, Beenish S.
    Lee, Todd A.
    Sharp, Lisa K.
    Walton, Surrey M.
    Galanter, William L.
    Nutescu, Edith A.
    PHARMACOTHERAPY, 2017, 37 (10): : 1221 - 1230
  • [42] Compliance and persistence with oral bisphosphonates for the treatment of osteoporosis in female patients with rheumatoid arthritis
    Park, Ji-Heh
    Park, Eun-Kyoung
    Koo, Dong-Wan
    Lee, Shinwon
    Lee, Sun-Hee
    Kim, Geun-Tae
    Lee, Seung-Geun
    BMC MUSCULOSKELETAL DISORDERS, 2017, 18
  • [43] Compliance and persistence with oral bisphosphonates for the treatment of osteoporosis in female patients with rheumatoid arthritis
    Ji-Heh Park
    Eun-Kyoung Park
    Dong-Wan Koo
    Shinwon Lee
    Sun-Hee Lee
    Geun-Tae Kim
    Seung-Geun Lee
    BMC Musculoskeletal Disorders, 18
  • [44] Retrospective evaluation of persistence in osteoporosis therapy with oral bisphosphonates in Italy: the TOBI study
    Stefano Gonnelli
    Carla Caffarelli
    Giulia Letizia Mauro
    Ombretta Di Munno
    Nazzarena Malavolta
    Silvia Migliaccio
    Ranuccio Nuti
    Aging Clinical and Experimental Research, 2019, 31 : 1541 - 1547
  • [45] Retrospective evaluation of persistence in osteoporosis therapy with oral bisphosphonates in Italy: the TOBI study
    Gonnelli, Stefano
    Caffarelli, Carla
    Mauro, Giulia Letizia
    Di Munno, Ombretta
    Malavolta, Nazzarena
    Migliaccio, Silvia
    Nuti, Ranuccio
    AGING CLINICAL AND EXPERIMENTAL RESEARCH, 2019, 31 (11) : 1541 - 1547
  • [46] Oral bisphosphonates are associated with low persistence and compliance (adherence) in patients with breast cancer
    不详
    EJC SUPPLEMENTS, 2006, 4 (02): : 166 - 166
  • [47] Real-World Persistence with Ocrelizumab in Multiple Sclerosis: a Systematic Review
    Petrie, John L.
    Smith, Charlie A.
    Fountain, Donna
    Machnicki, Gerardo
    NEUROLOGY AND THERAPY, 2024, 13 (06) : 1597 - 1605
  • [48] Treating Osteoporosis with Bisphosphonates and Addressing AdherenceA Review of Oral Ibandronate
    Charles H. Chesnut
    Drugs, 2006, 66 : 1351 - 1359
  • [49] Prior adherence to statins is a predictor of subsequent adherence and persistence to oral, but not parenteral, osteoporosis medications
    Ambika Gupta
    Mu Lin
    Finlay A. McAlister
    Carrie Ye
    Journal of Bone and Mineral Metabolism, 2021, 39 : 712 - 718
  • [50] Denosumab or oral bisphosphonates in primary osteoporosis: a "real-life" study
    Cairoli, E.
    Palmieri, S.
    Goggi, G.
    Roggero, L.
    Arosio, M.
    Chiodini, I.
    Eller-Vainicher, C.
    JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 2018, 41 (08): : 1005 - 1013